Cargando…
u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer
BACKGROUND: Peritoneal metastasis in gastric cancer represents a ubiquitous human health problem but effective therapies with limited side effects are still lacking. Although previous research suggested that u-PA was involved in some tumor metastasis such as lung-specific metastasis, the role of u-P...
Autores principales: | Ding, Youcheng, Zhang, Hui, Zhou, Zhuqing, Zhong, Mingan, Chen, Qiliang, Wang, Xujing, Zhu, Zhenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577507/ https://www.ncbi.nlm.nih.gov/pubmed/23234499 http://dx.doi.org/10.1186/1477-7819-10-270 |
Ejemplares similares
-
Clinical significance of the uPA system in gastric cancer with peritoneal metastasis
por: Ding, Youcheng, et al.
Publicado: (2013) -
Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors
por: Buckley, Benjamin J., et al.
Publicado: (2021) -
Antifungal activity of 6-substituted amiloride and hexamethylene amiloride (HMA) analogs
por: Vu, Kiem, et al.
Publicado: (2023) -
Amiloride: A review
por: Sun, Qianhui, et al.
Publicado: (2020) -
The Antifungal Activity of HMA, an Amiloride Analog and Inhibitor of Na(+)/H(+) Exchangers
por: Vu, Kiem, et al.
Publicado: (2021)